230 related articles for article (PubMed ID: 35409379)
1. Hypermethylation-Mediated Silencing of
Zorzan E; Elgendy R; Guerra G; Da Ros S; Gelain ME; Bonsembiante F; Garaffo G; Vitale N; Piva R; Marconato L; Aresu L; Dacasto M; Giantin M
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409379
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
Ferraresso S; Bresolin S; Aricò A; Comazzi S; Gelain ME; Riondato F; Bargelloni L; Marconato L; Kronnie Gt; Aresu L
PLoS One; 2014; 9(4):e92707. PubMed ID: 24695110
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.
Ferraresso S; Aricò A; Sanavia T; Da Ros S; Milan M; Cascione L; Comazzi S; Martini V; Giantin M; Di Camillo B; Mazzariol S; Giannuzzi D; Marconato L; Aresu L
Sci Rep; 2017 Sep; 7(1):11591. PubMed ID: 28912427
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation and RNA-seq analyses identify genes and pathways associated with doxorubicin resistance in a canine diffuse large B-cell lymphoma cell line.
Hsu CH; Tomiyasu H; Liao CH; Lin CS
PLoS One; 2021; 16(5):e0250013. PubMed ID: 33961622
[TBL] [Abstract][Full Text] [Related]
5. Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach.
Da Ros S; Aresu L; Ferraresso S; Zorzan E; Gaudio E; Bertoni F; Dacasto M; Giantin M
PLoS One; 2018; 13(12):e0208709. PubMed ID: 30533020
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
7. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
Haruki S; Imoto I; Kozaki K; Matsui T; Kawachi H; Komatsu S; Muramatsu T; Shimada Y; Kawano T; Inazawa J
Carcinogenesis; 2010 Jun; 31(6):1027-36. PubMed ID: 20200074
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
[TBL] [Abstract][Full Text] [Related]
10. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
11. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells.
Fujiwara-Igarashi A; Goto-Koshino Y; Mochizuki H; Sato M; Fujino Y; Ohno K; Tsujimoto H
Res Vet Sci; 2014 Aug; 97(1):60-3. PubMed ID: 24815345
[TBL] [Abstract][Full Text] [Related]
13. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
Wang XM; Greiner TC; Bibikova M; Pike BL; Siegmund KD; Sinha UK; Müschen M; Jaeger EB; Weisenburger DD; Chan WC; Shibata D; Fan JB; Hacia JG
J Cell Biochem; 2010 Mar; 109(4):818-27. PubMed ID: 20069569
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
[TBL] [Abstract][Full Text] [Related]
16. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
17. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
18. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
[TBL] [Abstract][Full Text] [Related]
19. Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.
Zhang YW; Zhang J; Li J; Zhu JF; Yang YL; Zhou LL; Hu ZL; Zhang F
Leuk Lymphoma; 2015; 56(8):2429-38. PubMed ID: 25487076
[TBL] [Abstract][Full Text] [Related]
20. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]